top of page

Grace Lawson-Rivers Group

Public·3 members
Rezo Frolov
Rezo Frolov

Berberis [TOP]



Layout table for study information Study Type : Interventional (Clinical Trial) ActualEnrollment : 78 participants Allocation: Randomized Intervention Model: Parallel Assignment Masking: Single (Investigator) Primary Purpose: Treatment Official Title: Effect of Berberis Vulgaris Consumption on Blood Pressure and Plasma Lipids in Subjects With Cardiovascular Risk Factors Actual Study Start Date : September 18, 2019 Actual Primary Completion Date : August 19, 2020 Actual Study Completion Date : October 21, 2020 Resource links provided by the National Library of Medicine Drug Information available for: Barberry Berberis vulgaris whole U.S. FDA Resources Arms and Interventions Go to Top of Page Study Description Study Design Arms and Interventions Outcome Measures Eligibility Criteria Contacts and Locations More Information Arm Intervention/treatment Active Comparator: BarberryDaily consumption of barberry in powder form. Dietary Supplement: berberis vulgaris=barberry10 grams of barberry powder will be consumed daily for 8 weeks. Placebo Comparator: placeboDaily consumption of placebo powder. Dietary Supplement: PlaceboPlacebo powder Outcome Measures Go to Top of Page Study Description Study Design Arms and Interventions Outcome Measures Eligibility Criteria Contacts and Locations More Information Primary Outcome Measures : blood pressure [ Time Frame: at 8 weeks ]mean of systolic and diastolic blood pressure of participants measured by ambulatory 24 hour blood pressure monitoring Secondary Outcome Measures : lipid profile [ Time Frame: at 8 weeks ]plasma TC, LDL-C, HDL-C, TG plasma NOx [ Time Frame: at 8 weeks ]concentration of nitrite and nitrate in plasma Inflammatory cytokine [ Time Frame: at 8 weeks ]Plasma Interleukin-6 Eligibility CriteriaGo to Top of Page Study Description Study Design Arms and Interventions Outcome Measures Eligibility Criteria Contacts and Locations More Information Information from the National Library of Medicine Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies. Layout table for eligibility information Ages Eligible for Study: 20 Years to 65 Years (Adult, Older Adult) Sexes Eligible for Study: All Accepts Healthy Volunteers: No Criteria Inclusion Criteria:




berberis

041b061a72


About

Welcome to the group! You can connect with other members, ge...

Members

bottom of page